Reuters logo
BRIEF-AVEO Oncology and EUSA Pharma announce TiNivo combination study opt-in
September 20, 2017 / 11:18 AM / in 2 months

BRIEF-AVEO Oncology and EUSA Pharma announce TiNivo combination study opt-in

Sept 20 (Reuters) - Aveo Pharmaceuticals Inc

* Aveo Pharmaceuticals Inc - ‍EUSA Pharma has agreed to pay AVEO up to $388 million in future milestone payments and research and development funding​

* Aveo - ‍under terms of agreement, EUSA may utilize data from study for regulatory/commercial purposes in exchange for research and development funding payment of $2.0 million​

* Aveo Pharmaceuticals Inc - ‍EUSA Pharma agreed to pay co milestone payments under terms of agreement from Dec 2015 ​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below